9/29/2023 | 30021500 | ORB809230 ACNA ANTIBODY (10 MG) (FOR RESEARCH USE) | XXXXXXXXXX | 1 | NOS | 1837.64 | UNITED KINGDOM | LONDON METROPOLITAN |
9/29/2023 | 30021500 | ORB832756 SODA ANTIBODY (10 MG) (FOR RESEARCH USE) | XXXXXXXXXX | 1 | NOS | 1837.64 | UNITED KINGDOM | LONDON METROPOLITAN |
9/15/2023 | 30021500 | BE0190 H CD152/H CTLA4 INVIVOMAB BN13, 1 MG[FOR RUO | XXXXXXXXXX | 1 | SET | 100.79 | USA | LONDON METROPOLITAN |
9/15/2023 | 30021500 | BE0071 M/H VLA-4 (CD49D) INVIVOMAB PS/2, 1 MG[FOR RUO | XXXXXXXXXX | 1 | SET | 100.79 | USA | LONDON METROPOLITAN |
9/15/2023 | 30021500 | BE0001-1 M CD3E INVIVOMAB 145-2C11, 25 MG[FOR RUO | XXXXXXXXXX | 1 | SET | 1240.91 | USA | LONDON METROPOLITAN |
9/15/2023 | 30021500 | BE0071 M/H VLA-4 (CD49D) INVIVOMAB PS/2, 5 MG[FOR RUO | XXXXXXXXXX | 1 | SET | 369.93 | USA | LONDON METROPOLITAN |
9/15/2023 | 30021500 | BE0003-1 M CD4 INVIVOMAB GK1.5, 100 MG [FOR RUO | XXXXXXXXXX | 1 | SET | 2643.3 | USA | LONDON METROPOLITAN |
9/15/2023 | 30021500 | BE0188 H CD279 (PD-1) INVIVOMAB J116, 1MG [FOR RUO | XXXXXXXXXX | 1 | SET | 100.79 | USA | LONDON METROPOLITAN |
9/14/2023 | 30021500 | NUCALA SOLUTION AI 100MG/ML 1X1 ML_IN-GSK (MEPOLIZUMAB SOLUTION FOR INJECTION) | XXXXXXXXXX | 480 | NOS | 104352.6 | UNITED KINGDOM | LONDON HEATHROW |
9/12/2023 | 30021500 | AB00812-10.0 ANTI-E-PROTEIN DIII (LR) ZV-67 (200UG) (FOR RESEARCH USE) | XXXXXXXXXX | 1 | NOS | 370.01 | UNITED KINGDOM | LONDON METROPOLITAN |